Madison Park Capital Advisors’s Genocea Biosciences, Inc. GNCA Stock Holding History

Madison Park Capital Advisors’s Portfolio GNCA Stock Details GNCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-10,000	Closed	-$1	–	83
2024 Q3	$1	Hold	10,000	–	–	﹤0.01%	75
2024 Q2	$0	Hold	10,000	–	–	﹤0.01%	83
2024 Q1	$0	Hold	10,000	–	–	﹤0.01%	73
2023 Q4	$1	Buy	+10,000	New	+$1	﹤0.01%	64

Madison Park Capital Advisors's GNCA Position: Q4 2024 in Review

Madison Park Capital Advisors sold out of Genocea Biosciences, Inc. (GNCA) in Q4 2024, closing a stake of 10,000 shares — an estimated $1 sold.

Madison Park Capital Advisors first reported a position in GNCA in Q4 2023 and held it in 4 quarters. The position peaked at $1 in Q3 2024. 1 fund tracked by Wall St. Rank holds GNCA as of Q4 2024.

Madison Park Capital Advisors reported no remaining Genocea Biosciences, Inc. position as of Q4 2024 after selling out during the quarter.
Madison Park Capital Advisors sold 10,000 Genocea Biosciences, Inc. shares in Q4 2024, an estimated $1.
Madison Park Capital Advisors first reported a position in Genocea Biosciences, Inc. in Q4 2023 and held it in 4 quarters.
Madison Park Capital Advisors's Genocea Biosciences, Inc. position peaked at $1 in Q3 2024.
1 fund tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q4 2024.

Based on Madison Park Capital Advisors's 13F filing for Q4 2024, filed 17 Jan 2025.